Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,262,299
-
Share change
-
+17,262,299
-
Total reported value
-
$297,816,000
-
Price per share
-
$17.35
-
Number of holders
-
41
-
Value change
-
+$297,816,030
-
Number of buys
-
41
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2018
As of 30 Jun 2018,
Kiniksa Pharmaceuticals Intern - COM (KNSA) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,262,299 shares.
The largest 10 holders included
Hillhouse Capital Management, Ltd., BAKER BROS. ADVISORS LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BOXER CAPITAL, LLC, Sofinnova Ventures Inc, FMR LLC, Cormorant Asset Management, LP, AMERIPRISE FINANCIAL INC, VHCP Management II, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.